Showing results (41-50 of 2,104) with videos related to
Sort By:
Pageof 211
CNS Drugs|March 23, 2021
First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor VafidemstatRosa María Antonijoan, Juan Manuel Ferrero-Cafiero, Jimena Coimbra, et al.CNS Drugs|February 15, 2012
The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?Paul Hodgkins, Monica Shaw, Suzanne McCarthy, et al.CNS Drugs|April 13, 2012
Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorderAlexandre Duarte Gigante, Beny Lafer, Lakshmi N YathamCNS Drugs|April 24, 2012
Taking the negative view of current migraine treatments: the unmet needsPeer Tfelt-Hansen, Jes OlesenCNS Drugs|April 24, 2012
Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorderRichard H Weisler, Gahan J Pandina, Ella J Daly, et al.CNS Drugs|December 17, 2011
Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosisHenrik Gensicke, David Leppert, Özgür Yaldizli, et al.CNS Drugs|June 25, 2011
Rituximab for secondary progressive multiple sclerosis: a case seriesPaulus S Rommer, Robert Patejdl, Alexander Winkelmann, et al.CNS Drugs|August 30, 2011
Role of serotonin in Alzheimer's disease: a new therapeutic target?Werner J Geldenhuys, Cornelis J Van der SchyfCNS Drugs|August 30, 2011
Targeting progressive neuroaxonal injury: lessons from multiple sclerosisAmit Bar-Or, Peter Rieckmann, Anthony Traboulsee, et al.CNS Drugs|July 28, 2011
Antipsychotic pharmacotherapy and orthostatic hypotension: identification and managementJames J GuggerPageof 211